X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs FULFORD INDIA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD FULFORD INDIA MERCK LTD/
FULFORD INDIA
 
P/E (TTM) x 33.5 398.8 8.4% View Chart
P/BV x 3.7 6.2 60.3% View Chart
Dividend Yield % 0.8 0.1 891.4%  

Financials

 MERCK LTD   FULFORD INDIA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
FULFORD INDIA
Mar-14
MERCK LTD/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,060942 112.5%   
Low Rs623450 138.4%   
Sales per share (Unadj.) Rs632.4691.4 91.5%  
Earnings per share (Unadj.) Rs45.711.5 398.9%  
Cash flow per share (Unadj.) Rs62.315.4 405.7%  
Dividends per share (Unadj.) Rs11.002.00 550.0%  
Dividend yield (eoy) %1.30.3 454.9%  
Book value per share (Unadj.) Rs388.8380.0 102.3%  
Shares outstanding (eoy) m16.603.90 425.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.0 132.2%   
Avg P/E ratio x18.460.7 30.3%  
P/CF ratio (eoy) x13.545.3 29.8%  
Price / Book Value ratio x2.21.8 118.2%  
Dividend payout %24.117.4 137.9%   
Avg Mkt Cap Rs m13,9692,714 514.6%   
No. of employees `0001.60.4 356.5%   
Total wages/salary Rs m1,487505 294.4%   
Avg. sales/employee Rs Th6,631.96,073.0 109.2%   
Avg. wages/employee Rs Th939.21,137.4 82.6%   
Avg. net profit/employee Rs Th479.4100.7 476.2%   
INCOME DATA
Net Sales Rs m10,4982,696 389.3%  
Other income Rs m242125 193.3%   
Total revenues Rs m10,7412,822 380.6%   
Gross profit Rs m1,135-46 -2,446.8%  
Depreciation Rs m27615 1,812.5%   
Interest Rs m010 0.0%   
Profit before tax Rs m1,10254 2,029.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34310 3,576.0%   
Profit after tax Rs m75945 1,697.8%  
Gross profit margin %10.8-1.7 -628.4%  
Effective tax rate %31.117.7 176.2%   
Net profit margin %7.21.7 436.1%  
BALANCE SHEET DATA
Current assets Rs m6,4101,738 368.7%   
Current liabilities Rs m8,828545 1,620.8%   
Net working cap to sales %-23.044.3 -52.0%  
Current ratio x0.73.2 22.7%  
Inventory Days Days5848 119.0%  
Debtors Days Days384 891.8%  
Net fixed assets Rs m1,40612 11,818.5%   
Share capital Rs m16639 425.6%   
"Free" reserves Rs m6,2861,443 435.6%   
Net worth Rs m6,4551,482 435.5%   
Long term debt Rs m00-   
Total assets Rs m8,8282,077 425.1%  
Interest coverage xNM6.7-  
Debt to equity ratio x00-  
Sales to assets ratio x1.21.3 91.6%   
Return on assets %8.62.6 329.4%  
Return on equity %11.83.0 389.8%  
Return on capital %17.14.3 396.7%  
Exports to sales %8.30-   
Imports to sales %21.024.5 86.1%   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209659 335.1%   
Fx inflow Rs m95917 5,574.4%   
Fx outflow Rs m2,612673 388.0%   
Net fx Rs m-1,653-656 252.0%   
CASH FLOW
From Operations Rs m1,07090 1,189.3%  
From Investments Rs m-750105 -716.7%  
From Financial Activity Rs m-150-14 1,062.4%  
Net Cashflow Rs m171181 94.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 3.8 478.9%  
FIIs % 1.0 0.1 1,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 21.2 137.3%  
Shareholders   28,591 4,783 597.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  ABBOTT INDIA  PLETHICO PHARMA  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 21, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - JUBILANT LIFE SCIENCES COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS